Literature DB >> 30473198

Neuroimaging Applications in Tourette's Syndrome.

Davide Martino1, Christos Ganos2, Yulia Worbe3.   

Abstract

Tics are neurodevelopmental hyperkinetic symptoms typically associated with unpleasant sensory experiences called premonitory urges. Tourette syndrome (TS) is the primary chronic tic disorder for which medical surveillance is most frequently required, and is associated with a complex phenotypical spectrum encompassing different types of abnormal behaviors. Animal models of tics support their link to phasic activity changes throughout the sensorimotor loop of the cortico-basal ganglia-thalamo-cortical network. Event-related functional magnetic resonance imaging (fMRI) studies on patients with TS showed that the supplementary motor area relays preparatory signals related to tics to the primary motor area and other cortical regions relevant to action monitoring, following which cortico-basal ganglia-thalamo-cortical activation leads to the manifestation of tics. Despite their methodological heterogeneity, structural MRI studies highlighted the existence of anatomical markers of distinct sub-phenotypes of the TS spectrum. Initial evidence suggests that combining MRI structural methods and functional intrinsic connectivity assessed during resting state could even discriminate between TS patients and control groups. MR-spectroscopy and positron emission tomography studies suggest that TS may be related to a complex interplay between different neurotransmitters (particularly dopamine, GABA and glutamate), but discrepancy across studies prevents firm conclusions. Recent volumetric, cortical thickness and fMRI studies results showed an association between premonitory urges and somatosensory and insular cortical regions, involved in the processing of interoceptive and enteroceptive stimuli and motor output modulation. Finally, both structural and functional MRI studies have provided important support to the subtyping of the TS spectrum with respect to behavioral co-morbidities, in line with a "dimensional approach" to the classification of neuropsychiatric disorders, which is based on the identification of neurocognitive endophenotypes and of their anatomical substrate.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PET; Spectroscopy; Structural MRI; Tourette syndrome; fMRI

Mesh:

Year:  2018        PMID: 30473198     DOI: 10.1016/bs.irn.2018.09.008

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  8 in total

Review 1.  Localising movement disorders in childhood.

Authors:  Nigel S Bamford; Kathryn McVicar
Journal:  Lancet Child Adolesc Health       Date:  2019-10-22

Review 2.  Tourette disorder and sleep.

Authors:  Justin L Blaty; Lourdes M DelRosso
Journal:  Biomed J       Date:  2022-01-12       Impact factor: 7.892

3.  Altered sense of agency in Gilles de la Tourette syndrome: behavioural, clinical and functional magnetic resonance imaging findings.

Authors:  Laura Zapparoli; Silvia Seghezzi; Francantonio Devoto; Marika Mariano; Giuseppe Banfi; Mauro Porta; Eraldo Paulesu
Journal:  Brain Commun       Date:  2020-11-19

Review 4.  Role of Ash1l in Tourette syndrome and other neurodevelopmental disorders.

Authors:  Cheng Zhang; Lulu Xu; Xueping Zheng; Shiguo Liu; Fengyuan Che
Journal:  Dev Neurobiol       Date:  2020-12-14       Impact factor: 3.964

5.  Impulsive prepotent actions and tics in Tourette disorder underpinned by a common neural network.

Authors:  Cyril Atkinson-Clement; Camille-Albane Porte; Astrid de Liege; Yanica Klein; Cecile Delorme; Benoit Beranger; Romain Valabregue; Cecile Gallea; Trevor W Robbins; Andreas Hartmann; Yulia Worbe
Journal:  Mol Psychiatry       Date:  2020-09-29       Impact factor: 15.992

6.  The sooner the better: clinical and neural correlates of impulsive choice in Tourette disorder.

Authors:  Cyril Atkinson-Clement; Astrid de Liege; Yanica Klein; Benoit Beranger; Romain Valabregue; Cecile Delorme; Emmanuel Roze; Emilio Fernandez-Egea; Andreas Hartmann; Trevor W Robbins; Yulia Worbe
Journal:  Transl Psychiatry       Date:  2021-11-03       Impact factor: 6.222

7.  Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota.

Authors:  Na Wang; Xinchen Wu; Qi Yang; Dingyue Wang; Zhao Wu; Yuanyuan Wei; Jieqiong Cui; Li Hong; Lei Xiong; Dongdong Qin
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

8.  Enhancing neuroimaging genetics through meta-analysis for Tourette syndrome (ENIGMA-TS): A worldwide platform for collaboration.

Authors:  Peristera Paschou; Yin Jin; Kirsten Müller-Vahl; Harald E Möller; Renata Rizzo; Pieter J Hoekstra; Veit Roessner; Nanette Mol Debes; Yulia Worbe; Andreas Hartmann; Pablo Mir; Danielle Cath; Irene Neuner; Heike Eichele; Chencheng Zhang; Katarzyna Lewandowska; Alexander Munchau; Julius Verrel; Richard Musil; Tim J Silk; Colleen A Hanlon; Emily D Bihun; Valerie Brandt; Andrea Dietrich; Natalie Forde; Christos Ganos; Deanna J Greene; Chunguang Chu; Michel J Grothe; Tamara Hershey; Piotr Janik; Jonathan M Koller; Juan Francisco Martin-Rodriguez; Karsten Müller; Stefano Palmucci; Adriana Prato; Shukti Ramkiran; Federica Saia; Natalia Szejko; Renzo Torrecuso; Zeynep Tumer; Anne Uhlmann; Tanja Veselinovic; Tomasz Wolańczyk; Jade-Jocelyne Zouki; Pritesh Jain; Apostolia Topaloudi; Mary Kaka; Zhiyu Yang; Petros Drineas; Sophia I Thomopoulos; Tonya White; Dick J Veltman; Lianne Schmaal; Dan J Stein; Jan Buitelaar; Barbara Franke; Odile van den Heuvel; Neda Jahanshad; Paul M Thompson; Kevin J Black
Journal:  Front Psychiatry       Date:  2022-08-18       Impact factor: 5.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.